default search action

combined dblp search
author search
venue search
publication search

ask others

Stanley Chika Onye

> Home > Persons

Person information

Refine list

refinements active!

zoomed in on ?? of ?? records

view refined list in

export refined list as

showing all ?? records

Journal Articles

see FAQ

What is the meaning of the colors in the publication lists?

2022
[j3]
- view
  authority control:
- export record
  dblp key:
  - journals/elektrik/OnyeDA22
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/elektrik/OnyeDA22
Stanley Chika Onye, Nazife Dimililer, Arif A. Akkeles:
Chemical disease relation extraction through the combination of multiple mention levels: RelSCAN+. Turkish J. Electr. Eng. Comput. Sci. 30(6): 2237-2253 (2022)
2020
[j2]
- view
  - electronic edition via DOI (open access)
  - references & citations
  authority control:
- export record
  dblp key:
  - journals/elektrik/OnyeDA20
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/elektrik/OnyeDA20
Stanley Chika Onye, Nazife Dimililer, Arif A. Akkeles:
Chemical disease relation extraction task using genetic algorithm with two novelvoting methods for classifier subset selection. Turkish J. Electr. Eng. Comput. Sci. 28(2): 1179-1196 (2020)
2018
[j1]
- view
  - electronic edition via DOI (open access)
  - references & citations
  authority control:
- export record
  dblp key:
  - journals/jbi/OnyeAD18
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/jbi/OnyeAD18
Stanley Chika Onye, Arif A. Akkeles, Nazife Dimililer:
relSCAN - A system for extracting chemical-induced disease relation from biomedical literature. J. Biomed. Informatics 87: 79-87 (2018)

Coauthor Index

see FAQ

manage site settings

To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.